Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Alzheimers Dement. 2013 Nov 13;10(0):S425–S429.e1. doi: 10.1016/j.jalz.2013.09.006

Figure 1.

Figure 1

Scatterplots showing the correlations between BACE1 activity and the concentrations of cerebrospinal fluid proteins (rows) in the different study groups (columns)

NL: normal controls; sMCI: stable mild cognitive impairment; pMCI: progressive mild cognitive impairment; AD: Alzheimer’s disease; BACE1: beta-site amyloid precursor protein cleaving enzyme 1; sAPPβ: soluble amyloid precursor protein β; tTau: total-Tau; pTau181: phosphorylated Tau181.